1/21
BPMH
therapeutic objectives for SUDs treatment
withdrawal syndrome prevention / treatment and detoxification
reduce withdrawal symptoms to encourage more people to go through detoxification
overdose treatment
methods of quickly ensuring a patients safety after an overdose
abstinence (enforcement and encouragement)
relapse prevention- monitoring and reducing effect of cues
harm reduction- instead of completely stopping drug use, making it as safe as possible
methadone
pharmacology → μ-opioid receptor (MOR) agonist. oral route of administration (injectable for pain control). long half-life
therapeutic use → prevention / treatment withdrawal syndrome. relapse prevention and detoxification
^reducing wanting for opioids and reducing symptoms
naloxone
pharmacology → MOR agonist. intravenous. short half life- fast acting
therapeutic use → ultra-rapid detoxification. reverse overdose
^helpful for patients in overdose
naltrexone
pharmacology → MOR antagonist. oral. longer half life
therapeutic use → enforcing abstinence in motivated people (blocks MORs to stop the rewarding feelings). also available in long-release forms
^ assisting abstinence
glucagon-like peptide (GLP-1) pathways
after eating, gut derived GLP-1 is released from the intestine and influences the brain via activation of the nerves and crossing of the BBB
endogenous GLP-1 activated neurons in the nucleus tractus solitarius (NTS)
NTS projects to the VTA, NAc, and hypothalamus, relating to food and reward recognition
why GLP-1 agonists treat addiction
still mostly unclear
may have relation to decreasing the rewarding / reinforcing effects of drugs, or increasing state of satiation
non-pharmacological treatment for SUDs
contingency management
community reinforcement approach
behavioural skills training, job skills training, social and recreational counselling, relapse prevention, relationship counselling
AA and other 12-step programs
mindfulness
CBT
motivational enhancement therapy
family therapy
contingency management
based on the principle of reward-learning and operant conditioning.
positive / negative reinforcement / punishment
examples of harm management
alcohol → interventions to reduce injury and violence, or to reduce road accidents
tobacco → making products safer, reducing risks to non-smokers
injecting drug use → needle syringe programmes, outreach, supervised injecting facilities, non-injecting routes of administration, education and info
behavioural addictions
described as the failure to resist an impulse, drive, or temptation to perform and act that is harmful to the person or others
historically classified by comparison to SUDs
SUDs have been long accepted, classified, treated, and studied
behavioural addictions are relatively new in comparison
they have similarities in underlying pathology, also many differences
DSM-5: gambling disorder
persistent and recurring problematic gambling behaviour leading to clinically significant impairment or distress. exhibits 4+ symptoms in 12 months
not better explained by a manic episode
SUDs and BAs can result in similar negative consequences
mental health problems
physical health problems
breakdown of relationships
homelessness / unhoused
crime
there is a high degree of lifetime comorbidity between pathological gambling disorder and other mental health conditions
similarities in vulnerabilities
between SUDs and gambling disorders, including:
young age
male sex
low socio-economic status
unpaired marital status
socio-economic issues around gambling example
casinos in areas of native / tribal communities have been helpful for funding healthcare and reducing mortality in those areas, especially when they are not supported well by federal government
however, studies have found that the incidence of problem gambling is 3-7 times greater in contemporary North American First Nation communities than in the general public
gaming disorder
future DSM - ‘internet gaming’
ICD-11 - not necessarily internet based
most who play video games do not become addicted. a recent study of 13-16 year olds found that 3% of online gamers displayed addictive symptomology
do we need new diagnostic criteria
BAs are accepted based on research highlighting the similarities with long-established SUD criteria
but when we use the same criteria, we don’t acknowledge pharmacological effects of drugs, and how they might have long-term consequences on mental and physical health
currently, for a mild diagnosis, 2-3 criteria are required for SUDs, vs 4-5 for a gambling disorder
there are no criteria for other BAs
is there a risk of pathologising normal behaviours and hobbies
biology and treatment of BAs
the VTA and NAc DA system is strongly implicated in mediated drug reward and gambling
DA and gambling - patient evidence
Parkinson’s is a neurodegenerative disease that results in the gradual loss of DA neurons
a treatment option is DA replacement therapy
treatments that involve giving patients D2/3 DA receptor agonists can facilitate gambling behaviour
impacts of DA signalling
increased D2 blood pressure in overall striatum leads to a decrease in negative urgency
acting rashly, impulsively, under distress
greater Da signalling may be observed in the ventral striatum or midbrain for people who gamble despite problems
altered striatal DA NT may also be associated with internet addiction
resemblance to incentive salience model of addiction
with repeated drug or gambling exposure, wanting may become enhances (sensitised), a process facilitated by increased DA transmission
excessive wanting can lead to addictive behaviours, even when pleasure associated with the activity decreases
this is magnified by experience with uncertainty and reward-predictive cues (which are salient and can drive relapse)
gambling cues and urges
it is possible that decision making during gambling is influenced by conditional stimuli (cues) that are associated with winning and losing
gambling environments (and commercials) are full of AV stimuli designed to drive betting behaviour
people who experience problematic / harmful gambling may allocate excess attention to betting-related cues
stimuli exposure impacts physiology and cognitive-behavioural states
therapies for BAs such as gambling disorder
drug therapies - e.g. naltrexone
psychological therapies are most commonly used to treat BAs
CBT, family therapy
social support